Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma

Sulkowska,Urszula; Febp,Andrzej Wincewicz; Sulkowski,Stanislaw

doi:10.3892/ol.2016.4550

Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma

Authors:
- Urszula Sulkowska
- Andrzej Wincewicz Febp
- Stanislaw Sulkowski
View Affiliations

Affiliations: Department of General Pathomorphology, Medical University of Bialystok, Bialystok 15‑269, Poland, Department of Pathology, Faculty of Medicine and Health Sciences, Jan Kochanowski Memorial University, Kielce 25‑317, Poland
Published online on: May 9, 2016 https://doi.org/10.3892/ol.2016.4550
Pages: 4134-4138

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Signal transducer and activator of transcription‑3 (STAT3) drives endometrial carcinogenesis, while signaling via gap junctions gets weakened during cancer progression. Connexin 26 (Cx26), Cx43 and STAT3 were immunohistochemically evaluated in 78 endometrioid adenocarcinomas: Nuclear expression of STAT3 positively correlated with cytoplasmic immunoreactivity to Cx43 (P=0.004, r=0.318) and Cx26 (P=0.006, r=0.309). STAT3 correlated with Cx43 (P=0.022, r=0.411) and Cx26 (P=0.008 r=0.466) in G1 tumors. A statistically significant linkage remained in G2 cancers between STAT3 and Cx43 (P=0.061, r=0.262) and Cx26 (P=0.016, r=0.331); however, no correlations were observed in G3 tumors. STAT3 was significantly associated with Cx 43 (p=0.003, r=0.684) and Cx26 (p=0.049, r=0.500) in estrogen receptor (ER) negative adenocarcinomas. STAT3 did not correlate with Cx43 in ER positive adenocarcinomas; however, STAT3 expression remained correlated with Cx26 expression (P=0.035, r=0.268). In progesterone receptor negative tumors STAT3 was significantly associated with Cx43 (P=0.035, r=0.451) and Cx26 (P<0.0001, r=0.707). However, in PgR positive adenocarcinomas STAT3 correlated with Cx43 (P=0.03, r=0.290) but not with Cx26. Thus, it appears that hormone dependent acceleration of cancer growth breaks the association between STAT3 and Cx expression. These associations become weaker as the tumors dedifferentiate from G1 to G3 endometrioid adenocarcinomas. The present study provides evidence that the loss of correlation between STAT3 and selected Cx proteins occurs in tumors with more aggressive behavior.

View Figures

View References

1	Saito T, Nishimura M, Kudo R and Yamasaki H: Suppressed gap junctional intercellular communication in carcinogenesis of endometrium. Int J Cancer. 93:317–323. 2001. View Article : Google Scholar : PubMed/NCBI
2	Nishimura M, Saito T, Yamasaki H and Kudo R: Suppression of gap junctional intercellular communication via 5′ CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. Carcinogenesis. 24:1615–1623. 2003. View Article : Google Scholar : PubMed/NCBI
3	Geletu M, Chaize C, Arulanandam R, Vultur A, Kowolik C, Anagnostopoulou A, Jove R and Raptis L: Stat3 activity is required for gap junctional permeability in normal rat liver epithelial cells. DNA Cell Biol. 28:319–327. 2009. View Article : Google Scholar : PubMed/NCBI
4	Fujimoto E, Sato H, Shirai S, Nagashima Y, Fukumoto K, Hagiwara H, Negishi E, Ueno K, Omori Y, Yamasaki H, et al: Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line. Oncogene. 24:3684–3690. 2005. View Article : Google Scholar : PubMed/NCBI
5	Geletu M, Trotman-Grant A and Raptis L: Mind the gap; regulation of gap junctional, intercellular communication by the SRC oncogene product and its effectors. Anticancer Res. 32:4245–4250. 2012.PubMed/NCBI
6	Geletu M, Arulanandam R, Greer S, Trotman-Grant A, Tomai E and Raptis L: Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells. BMC Cancer. 12:6052012. View Article : Google Scholar : PubMed/NCBI
7	Guy S, Geletu M, Arulanandam R and Raptis L: Stat3 and gap junctions in normal and lung cancer cells. Cancers (Basel). 6:646–662. 2014. View Article : Google Scholar : PubMed/NCBI
8	Sánchez JA, Rodríguez-Sinovas A, Barba I, Miró-Casas E, Fernández-Sanz C, Ruiz-Meana M, Alburquerque-Béjar JJ and García-Dorado D: Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection. Basic Res Cardiol. 108:3512013. View Article : Google Scholar : PubMed/NCBI
9	Rajasingh J, Bord E, Hamada H, Lambers E, Qin G, Losordo DW and Kishore R: STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: Analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction. Circ Res. 101:910–918. 2007. View Article : Google Scholar : PubMed/NCBI
10	Wincewicz A, Koda M, Sulkowska M, Kanczuga-Koda L and Sulkowski S: Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas. Tissue Cell. 40:405–410. 2008. View Article : Google Scholar : PubMed/NCBI
11	World Medical Association. 2004.WMA declaration of Helsinki: Ethical principles for medical research involving human subjects. http://www.wma.net/en/30publications/10policies/b3/Accessed. January. 2016
12	Lesniewicz T, Kanczuga-Koda L, Baltaziak M, Jarzabek K, Rutkowski R, Koda M, Wincewicz A, Sulkowska M and Sulkowski S: Comparative evaluation of estrogen and progesterone receptor expression with connexins 26 and 43 in endometrial cancer. Int J Gynecol Cancer. 19:1253–1257. 2009. View Article : Google Scholar : PubMed/NCBI
13	Wincewicz A, Baltaziak M, Kanczuga-Koda L, Koda M, Sulkowska U, Famulski W and Sulkowski S: STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile. Gynecol Endocrinol. 27:536–540. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kanczuga-Koda L, Wincewicz A, Fudala A, Abrycki T, Famulski W, Baltaziak M, Sulkowski S and Koda M: E-cadherin and β-catenin adhesion proteins correlate positively with connexins in colorectal cancer. Oncol Lett. 7:1863–1870. 2014.PubMed/NCBI
15	Saito T, Tanaka R, Wataba K, Kudo R and Yamasaki H: Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells. Oncogene. 23:1109–1116. 2004. View Article : Google Scholar : PubMed/NCBI
16	Tang JZ, Kong XJ, Banerjee A, Muniraj N, Pandey V, Steiner M, Perry JK, Zhu T, Liu DX and Lobie PE: STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone. Endocrinology. 151:4133–4145. 2010. View Article : Google Scholar : PubMed/NCBI
17	Ozog MA, Bernier SM, Bates DC, Chatterjee B, Lo CW and Naus CC: The complex of ciliary neurotrophic factor-ciliary neurotrophic factor receptor alpha up-regulates connexin43 and intercellular coupling in astrocytes via the Janus tyrosine kinase/signal transducer and activator of transcription pathway. Mol Biol Cell. 15:4761–4764. 2004. View Article : Google Scholar : PubMed/NCBI
18	Lesniewicz T, Kanczuga-Koda L, Baltaziak M, Sulkowska M, Rutkowski R, Koda M and Sulkowski S: Expression of connexin 26 in endometrial adenocarcinoma-analysis of correlations with some anatomoclinical features. Folia Histochem Cytobiol. 46:171–176. 2008. View Article : Google Scholar : PubMed/NCBI
19	Teleki I, Szasz AM, Maros ME, Gyorffy B, Kulka J, Meggyeshazi N, Kiszner G, Balla P, Samu A and Krenacs T: Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis. PLoS One. 9:e1125412014. View Article : Google Scholar : PubMed/NCBI
20	Teleki I, Krenacs T, Szasz MA, Kulka J, Wichmann B, Leo C, Papassotiropoulos B, Riemenschnitter C, Moch H and Varga Z: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer. 13:502013. View Article : Google Scholar : PubMed/NCBI
21	Schlemmer SR, Novotny DB and Kaufman DG: Changes in connexin 43 protein expression in human endometrial carcinoma. Exp Mol Pathol. 67:150–163. 1999. View Article : Google Scholar : PubMed/NCBI
22	Nakamura Y, Chang CC, Mori T, Sato K, Ohtsuki K, Upham BL and Trosko JE: Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis. 26:665–671. 2005. View Article : Google Scholar : PubMed/NCBI
23	Méndez-López LF, Dávila-Rodríguez MI, Zavala-Pompa A, Torres-López E, González-Martínez BE and López-Cabanillas-Lomelí M: Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients. Biomed Rep. 1:659–663. 2013.PubMed/NCBI
24	Lay V, Yap J, Sonderegger S and Dimitriadis E: Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. Int J Oncol. 41:759–764. 2012.PubMed/NCBI
25	Yang J, Liu B, Wang Q, Yuan D, Hong X, Yang Y and Tao L: Connexin 32 and its derived homotypic gap junctional intercellular communication inhibit the migration and invasion of transfected HeLa cells via enhancement of intercellular adhesion. Mol Med Rep. 4:971–979. 2011.PubMed/NCBI
26	Zhu M, Che Q, Liao Y, Wang H, Wang J, Chen Z, Wang F, Dai C and Wan X: Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis. Oncol Rep. 34:129–138. 2015.PubMed/NCBI
27	Sulkowska U, Wincewicz A, Kanczuga-Koda L, Koda M and Sulkowski S: Eventual proapoptotic or anti-apoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ER-alpha overexpression in human endometrioid adenocarcinoma. Gynecol Endocrinol. 31:604–608. 2015. View Article : Google Scholar : PubMed/NCBI